Literature DB >> 12567391

Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthma.

Mark Parry-Billings1, Claire Birrell, Louise Oldham, Christopher O'Callaghan.   

Abstract

Dry powder inhalers (DPIs) are increasingly being used to deliver drugs for the treatment of asthma. Both the aerosolization and delivery of the drug from a DPI to the lung are dependent on an adequate inspiratory effort from the patient, and it is well-known that the air flow achieved early in the inspiratory profile is important in determining particle size distribution from the inhaler. The present study assessed the peak inspiratory flow (PIF) generated through the Clickhaler DPI, and the early inspiratory flow at 150 mL of inspired volume (IF(150)), in asthmatic children. These measurements were made in a well-controlled setting, and two attempts were recorded to establish maximum achievement. Results were obtained from 57 children aged 6-17 years, showing a (mean +/- SD) best PIF of 60.5 +/- 18.7 L/min (range, 26.8-97.0). The mean PIF overall was 54.2 +/- 20.8 L/min (7.9-97.0). For children aged 6-8 years, the mean best PIF was 46.5 +/- 14.6 L/min (26.8-71.1); for those aged 9 years or more, it was >65 L/min (30.3-97.0). PIF values were unrelated to % predicted FEV(1) measurements. Best IF(150) (mean +/- SD) was 42.9 +/- 13.6 L/min (23.1-66.6) in children aged 6-8 years, and >55 L/min (28.0-86.4) for the older children, showing that high flow rates were achieved early in the inspiratory profile. These data indicate that children with stable asthma can generate adequate inspiratory flow rates to operate the Clickhaler effectively. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12567391     DOI: 10.1002/ppul.10234

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization.

Authors:  Catherine H Richardson; Marcel de Matas; Harold Hosker; Rahul Mukherjee; Ian Wong; Henry Chrystyn
Journal:  Pharm Res       Date:  2007-05-18       Impact factor: 4.200

2.  Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension.

Authors:  Mariana Faria-Urbina; Keith T Ung; Laurie Lawler; Lawrence S Zisman; Aaron B Waxman
Journal:  Pulm Circ       Date:  2021-05-13       Impact factor: 3.017

Review 3.  The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.

Authors:  Andrew R Clark; Jeffry G Weers; Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-31       Impact factor: 2.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.